Brief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
18/04/2024 17:08
April 18 (Reuters) - Theranexus SA ALTHX.PA :
* THERANEXUS AND BBDF ANNOUNCE FINAL AND POSITIVE SAFETY AND
EFFICACY DATA IN THE PHASE I/II TRIAL TESTING BATTEN-1
Source text for Eikon: ID:nACT85155
Further company coverage: ALTHX.PA
((Reuters.briefs@thomsonreuters.com;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease